Hermetica Superfood Encyclopedia
The Short Answer
Icariin is a prenylated flavonol glycoside isolated from Epimedium species that promotes bone formation through cAMP/PKA/CREB signaling activation. This bioactive compound enhances osteoblast activity and reverses bone loss by modulating osteoprotegerin pathways.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary Keywordicariin benefits
Synergy Pairings5
Icariin (Flavonol Glycoside) — botanical close-up
Health Benefits
Origin & History
Natural habitat
Icariin is a prenylated flavonol glycoside (C₃₃H₄₀O₁₅) primarily extracted from plants in the Epimedium genus, commonly known as Horny Goat Weed. It is isolated as a light yellow to yellow powder with >96% purity via HPLC from this traditional Chinese medicinal herb.
“Icariin is isolated from Epimedium, a traditional Chinese medicine (TCM) herb historically used for treating bone fractures and preventing osteoporosis. The herb has been used in traditional Chinese medicine for an extended historical period, though specific duration details are not provided.”Traditional Medicine
Scientific Research
Current research on icariin is limited to preclinical animal models and in vitro studies, with no human clinical trials, RCTs, or meta-analyses reported in the available literature. Studies include rat models examining bone mass development and mouse models investigating bone formation pathways, but no PubMed PMIDs for human trials were identified.
Preparation & Dosage
Traditional preparation
No clinically studied dosage ranges for humans have been established, as human trials are absent from the current research literature. Preclinical studies used icariin in animal models without specifying standardized doses for human use. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
{"macronutrients": {"protein": "Not applicable", "fiber": "Not applicable"}, "micronutrients": {"vitamins": "Not applicable", "minerals": "Not applicable"}, "bioactive_compounds": {"icariin": "Concentration varies depending on the source, typically found in concentrations ranging from 0.1% to 5% in Epimedium species extracts"}, "bioavailability_notes": "Icariin's bioavailability is generally low due to poor water solubility and rapid metabolism, but it can be improved through formulation strategies such as nanoparticles or phospholipid complexes."}
How It Works
Mechanism of Action
Icariin activates the cAMP/PKA/CREB signaling cascade in osteoblasts, promoting bone matrix synthesis and mineralization. The compound enhances peak bone mass development through primary cilia-localized signaling pathways and modulates the osteoprotegerin/RANKL system. Additionally, icariin demonstrates PDE5 inhibitory activity and influences estrogen receptor pathways.
Clinical Evidence
Current evidence for icariin is primarily derived from rat models and in vitro cell studies rather than human clinical trials. Rat studies show enhanced bone formation and reversal of osteoprotegerin-deficient bone loss, with young rat models demonstrating improved peak bone mass development. Cell culture studies confirm osteoblast activation and increased bone matrix protein expression. However, human clinical data remains limited, making it difficult to establish definitive therapeutic efficacy and optimal dosing protocols.
Safety & Interactions
Icariin is generally well-tolerated in animal studies, but human safety data is limited. Due to its PDE5 inhibitory activity, icariin may potentially interact with nitrates and blood pressure medications. The compound may also influence hormonal pathways, raising concerns for individuals with hormone-sensitive conditions. Pregnancy and breastfeeding safety has not been established, and consultation with healthcare providers is recommended before supplementation.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
C₃₃H₄₀O₁₅IcarisideHorny Goat Weed extractYin Yang Huo active compoundEpimedium flavonoidPrenylated flavonol glycosideBarrenwort extract
Frequently Asked Questions
What is the typical icariin dosage for bone health?
Human dosage guidelines are not well-established due to limited clinical trials. Animal studies used doses equivalent to 10-50mg per day in humans, but optimal therapeutic doses require further clinical research.
How long does icariin take to show bone health effects?
Rat studies showed measurable bone formation improvements within 4-8 weeks of treatment. However, human bone remodeling typically takes 3-6 months, so effects may require longer-term supplementation.
Can icariin be taken with calcium and vitamin D supplements?
No known contraindications exist between icariin and bone health supplements like calcium or vitamin D. The mechanisms are complementary, as icariin enhances osteoblast signaling while calcium provides building material for bone matrix.
Is icariin safe for postmenopausal women with osteoporosis?
While animal studies suggest bone-protective effects, human safety data is insufficient for postmenopausal women. Potential hormonal interactions require medical supervision, especially for those on hormone replacement therapy or osteoporosis medications.
What's the difference between icariin and horny goat weed extract?
Icariin is the specific bioactive flavonoid compound, while horny goat weed (Epimedium) extract contains multiple compounds including varying icariin concentrations. Standardized icariin supplements provide more consistent dosing than whole plant extracts.
Does icariin absorption improve when taken with food or fat?
Icariin is a flavonol glycoside with moderate lipophilicity, suggesting that absorption may be enhanced when consumed with dietary fat, though human bioavailability studies remain limited. Most preclinical research has not specifically evaluated food-fat interactions with icariin supplementation. Taking icariin with meals is generally recommended to support gastrointestinal tolerance and potentially optimize absorption, similar to other flavonoid compounds.
Does icariin interact with osteoporosis medications like bisphosphonates?
No significant drug interactions between icariin and bisphosphonates have been documented in clinical literature, as they work through distinct mechanisms (icariin activates osteoblast signaling while bisphosphonates inhibit osteoclast activity). However, because both target bone metabolism, combining them should be discussed with a healthcare provider to ensure complementary rather than redundant therapeutic effects. Separating administration timing may be prudent, though specific guidance is not yet established.
What does the clinical evidence show about icariin's effectiveness compared to standard osteoporosis treatments?
Most evidence for icariin comes from preclinical studies in animal models and cell cultures showing promise in bone formation and Wnt/β-catenin signaling activation, but human clinical trials remain sparse and small-scale. Available human studies suggest modest benefits for bone mineral density and bone turnover markers, though they lack the robust long-term safety and efficacy data available for FDA-approved osteoporosis drugs. Icariin may be better considered as a complementary approach rather than a replacement for established pharmacological treatments in moderate-to-severe osteoporosis.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w icariin curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
